{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:50:13Z","timestamp":1768071013860,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:00:00Z","timestamp":1502064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00066-017-1188-8","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T13:00:29Z","timestamp":1502110829000},"page":"1024-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Low-dose total skin electron beam therapy for cutaneous lymphoma","Niedrigdosis-Ganzhautelektronenbestrahlung bei Patienten mit kutanen Lymphomen"],"prefix":"10.1007","volume":"193","author":[{"given":"Kai","family":"Kroeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Elsayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Moustakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Haverkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"issue":"18","key":"1188_CR1","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.ccr-12-0604","volume":"18","author":"R Talpur","year":"2012","unstructured":"Talpur R, Singh L, Daulat S et al (2012) Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009. Clin Cancer Res 18(18):5051\u20135060. doi:\n                        10.1158\/1078-0432.ccr-12-0604","journal-title":"Clin Cancer Res"},{"issue":"31","key":"1188_CR2","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/jco.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S et\u00a0al (2010) Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J\u00a0Clin Oncol 28(31):4730\u20134739. doi:\n                        10.1200\/jco.2009.27.7665","journal-title":"J Clin Oncol"},{"issue":"5","key":"1188_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000475634","volume":"40","author":"K Elsayad","year":"2017","unstructured":"Elsayad K, Susek KH, Eich HT (2017) Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T\u2011cell lymphoma. Oncol Res Treat 40(5):244\u2013252. doi:\n                        10.1159\/000475634","journal-title":"Oncol Res Treat"},{"issue":"Suppl 1","key":"1188_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1610-0387.2008.06710.x","volume":"6","author":"R Stadler","year":"2008","unstructured":"Stadler R, Assaf C, Klemke C\u2011D et al (2008) Short German guidelines: cutaneous lymphomas. J\u00a0Dtsch Dermatol Ges 6(Suppl 1):31. doi:\n                        10.1111\/j.1610-0387.2008.06710.x","journal-title":"J Dtsch Dermatol Ges"},{"issue":"Suppl 6","key":"1188_CR5","doi-asserted-by":"publisher","first-page":"vi149","DOI":"10.1093\/annonc\/mdt242","volume":"24","author":"R Willemze","year":"2013","unstructured":"Willemze R, Hodak E, Zinzani PL et al (2013) Primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi149\u2013vi154. doi:\n                        10.1093\/annonc\/mdt242","journal-title":"Ann Oncol"},{"issue":"0","key":"1188_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","volume":"77","author":"F Trautinger","year":"2017","unstructured":"Trautinger F, Eder J, Assaf C et\u00a0al (2017) European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome \u2013 update 2017. Eur J Cancer 77(0):57\u201374. doi:\n                        10.1016\/j.ejca.2017.02.027","journal-title":"Eur J Cancer"},{"issue":"5","key":"1188_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000475528","volume":"40","author":"RT Hoppe","year":"2017","unstructured":"Hoppe RT (2017) Remarkable advances in the management of mycosis fungoides and the Sezary syndrome. Oncol Res Treat 40(5):242\u2013243. doi:\n                        10.1159\/000475528","journal-title":"Oncol Res Treat"},{"issue":"4","key":"1188_CR8","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","volume":"81","author":"C Harrison","year":"2011","unstructured":"Harrison C, Young J, Navi D et al (2011) Revisiting low-dose total skin electron beam therapy in mycosis fungoides. Int J Radiat Oncol Biol Phys 81(4):e651\u2013e657. doi:\n                        10.1016\/j.ijrobp.2011.01.023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"1188_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ijrobp.2013.04.042","volume":"86","author":"SL Morris","year":"2013","unstructured":"Morris SL, McGovern M, Bayne S et al (2013) Results of a\u00a05-week schedule of modern total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys 86(5):936\u2013941. doi:\n                        10.1016\/j.ijrobp.2013.04.042","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"1188_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jaad.2013.04.063","volume":"69","author":"S Lloyd","year":"2013","unstructured":"Lloyd S, Chen Z, Foss FM et\u00a0al (2013) Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides. J\u00a0Am Acad Dermatol 69(4):537\u2013543. doi:\n                        10.1016\/j.jaad.2013.04.063","journal-title":"J. Am. Acad. Dermatol."},{"issue":"13","key":"1188_CR11","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1200\/jco.2003.09.542","volume":"21","author":"RLM Haas","year":"2003","unstructured":"Haas RLM, Poortmans P, de Jong D et al (2003) High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J\u00a0Clin Oncol 21(13):2474\u20132480. doi:\n                        10.1200\/jco.2003.09.542","journal-title":"J Clin Oncol"},{"issue":"1","key":"1188_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry L, Smith P, Qian W et al (2011) Reduced dose radiotherapy for local control in Non-Hodgkin lymphoma: a\u00a0randomised phase III trial. Radiother Oncol 100(1):86\u201392. doi:\n                        10.1016\/j.radonc.2011.05.013","journal-title":"Radiother Oncol"},{"issue":"11","key":"1188_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s00066-014-0728-8","volume":"190","author":"K Herfarth","year":"2014","unstructured":"Herfarth K, Koenig L (2014) Radiotherapy (4\u202fGy vs. 24\u202fGy) of patients with indolent Non-Hodgkin-Lymphoma. Strahlenther Onkol 190(11):1084\u20131085. doi:\n                        10.1007\/s00066-014-0728-8","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"1188_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00066-016-0962-3","volume":"192","author":"L Koenig","year":"2016","unstructured":"Koenig L, Stade R, Rieber J et\u00a0al (2016) Radiotherapy of indolent orbital lymphomas two radiation concepts. Strahlenther Onkol 192(6):414\u2013421. doi:\n                        10.1007\/s00066-016-0962-3","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1188_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00066-016-1006-8","volume":"193","author":"O Habibeh","year":"2017","unstructured":"Habibeh O, Elsayad K, Kriz J et al (2017) Lymphoproliferative Erkrankung nach Transplantation erfolgreich durch konsolidierende Bestrahlung behandelt (Post-transplant lymphoproliferative disorder in the pelvis successfully treated with consolidative radiotherapy). Strahlenther Onkol 193(1):80\u201385. doi:\n                        10.1007\/s00066-016-1006-8","journal-title":"Strahlenther Onkol"},{"issue":"Suppl 1","key":"1188_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00066-016-0974-z","volume":"192","author":"K Elsayad","year":"2016","unstructured":"Elsayad K, Kriz J, Moustakis C et al (2016) Die Renaissance der Ganzhautelektronenbestrahlung zur Behandlung prim\u00e4r kutaner T\u2011Zell-Lymphome: NiedrBehandlung prim\u00e4r kutaner T\u2011Zell-Lymphome: Niedrigig vs. konventionell dosierte Radiotherapie (Abstracts DEGRO 2016). Strahlenther Onkol 192(Suppl 1):142. doi:\n                        10.1007\/s00066-016-0974-z","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"1188_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","volume":"72","author":"RT Hoppe","year":"2015","unstructured":"Hoppe RT, Harrison C, Tavallaee M et al (2015) Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a\u00a0pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol 72(2):286\u2013292. doi:\n                        10.1016\/j.jaad.2014.10.014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"1188_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","volume":"92","author":"MR Kamstrup","year":"2015","unstructured":"Kamstrup MR, Gniadecki R, Iversen L et al (2015) Low-dose (10-Gy) total skin electron beam therapy for cutaneous T\u2011cell lymphoma: an open clinical study and pooled data analysis. Int J Radiat Oncol Biol Phys 92(1):138\u2013143. doi:\n                        10.1016\/j.ijrobp.2015.01.047","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"1188_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00432-016-2338-6","volume":"143","author":"K Elsayad","year":"2017","unstructured":"Elsayad K, Oertel M, Haverkamp U et\u00a0al (2017) The effectiveness of radiotherapy for leukemia cutis. J\u00a0Cancer Res Clin Oncol 143(5):851\u2013859. doi:\n                        10.1007\/s00432-016-2338-6","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"1188_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000470845","volume":"40","author":"B Dabaja","year":"2017","unstructured":"Dabaja B (2017) Renaissance of low-dose radiotherapy concepts for cutaneous lymphomas. Oncol Res Treat 40(5):255\u2013260. doi:\n                        10.1159\/000470845","journal-title":"Oncol Res Treat"},{"key":"1188_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.05.052","author":"SL Morris","year":"2017","unstructured":"Morris SL, Scarisbrick J, Frew JJ et\u00a0al (2017) The results of low dose total skin electron beam radiotherapy (TSEB), in patients with mycosis fungoides from the UK cutaneous lymphoma group. Int J Radiat Oncol Biol Phys. doi:\n                        10.1016\/j.ijrobp.2017.05.052","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"1188_CR22","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ijrobp.2015.08.041","volume":"93","author":"K Elsayad","year":"2015","unstructured":"Elsayad K, Kriz J, Moustakis C et al (2015) Total skin electron beam for primary cutaneous T\u2011cell lymphoma. Int J Radiat Oncol Biol Phys 93(5):1077\u20131086. doi:\n                        10.1016\/j.ijrobp.2015.08.041","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"1188_CR23","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3109\/0284186x.2011.585999","volume":"50","author":"LM Lindahl","year":"2011","unstructured":"Lindahl LM, Kamstrup MR, Petersen PM et al (2011) Total skin electron beam therapy for cutaneous T\u2011cell lymphoma: a\u00a0nationwide cohort study from Denmark. Acta Oncol (Madr) 50(8):1199\u20131205. doi:\n                        10.3109\/0284186x.2011.585999","journal-title":"Acta Oncol (Madr)"},{"issue":"4","key":"1188_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/archderm.131.4.432","volume":"131","author":"AG Licata","year":"1995","unstructured":"Licata AG (1995) Malignant melanoma and other second cutaneous malignancies in cutaneous T\u2011cell lymphoma. The influence of additional therapy after total skin electron beam radiation. Arch Dermatol 131(4):432\u2013435. doi:\n                        10.1001\/archderm.131.4.432","journal-title":"Arch Dermatol"},{"key":"1188_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0360-3016(94)90825-7","volume":"30","author":"LD Wilson","year":"1994","unstructured":"Wilson LD, Quiros PA, Kolenik S et al (1994) Additional courses of total skin electron beam therapy [TSEBT] in the retreatment of patients with cutaneous t\u2011cell lymphoma [CTCL]. Int J Radiat Oncol Biol Phys 30:269. doi:\n                        10.1016\/0360-3016(94)90825-7","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"1188_CR26","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/0360-3016(94)00590-h","volume":"32","author":"M Becker","year":"1995","unstructured":"Becker M, Hoppe RT, Knox SJ (1995) Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Int J Radiat Oncol Biol Phys 32(5):1445\u20131449. doi:\n                        10.1016\/0360-3016(94)00590-h","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"1188_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","volume":"147","author":"D Navi","year":"2011","unstructured":"Navi D, Riaz N, Levin YS et al (2011) The stanford university experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides. Arch Dermatol 147(5):561. doi:\n                        10.1001\/archdermatol.2011.98","journal-title":"Arch Dermatol"},{"issue":"2","key":"1188_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","volume":"72","author":"RT Hoppe","year":"2015","unstructured":"Hoppe RT, Harrison C, Tavallaee M et al (2015) Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides. Results of a\u00a0pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol 72(2):286\u2013292. doi:\n                        10.1016\/j.jaad.2014.10.014","journal-title":"J. Am. Acad. Dermatol."},{"key":"1188_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","volume":"77","author":"F Trautinger","year":"2017","unstructured":"Trautinger F, Eder J, Assaf C et\u00a0al (2017) European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 update 2017. Eur J Cancer 77:57\u201374. doi:\n                        10.1016\/j.ejca.2017.02.027","journal-title":"Eur J Cancer"},{"issue":"11","key":"1188_CR30","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1182\/blood-2006-12-062877","volume":"109","author":"YH Kim","year":"2007","unstructured":"Kim YH, Duvic M, Obitz E et al (2007) Clinical efficacy of zanolimumab (HuMax-CD4). Two phase 2 studies in refractory cutaneous T\u2011cell lymphoma. Blood 109(11):4655\u20134662. doi:\n                        10.1182\/blood-2006-12-062877","journal-title":"Blood"},{"issue":"3","key":"1188_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/bjd.12690","volume":"170","author":"A Masson de","year":"2014","unstructured":"de Masson A, Guitera P, Brice P et al (2014) Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T\u2011cell lymphomas. Br J Dermatol 170(3):720\u2013724. doi:\n                        10.1111\/bjd.12690","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"1188_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1200\/jco.2013.52.0924","volume":"32","author":"M Ogura","year":"2014","unstructured":"Ogura M, Ishida T, Hatake K et al (2014) Multicenter phase II study of mogamulizumab (KW-0761), a\u00a0defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T\u2011cell lymphoma and cutaneous T\u2011cell lymphoma. J\u00a0Clin Oncol 32(11):1157\u20131163. doi:\n                        10.1200\/jco.2013.52.0924","journal-title":"J Clin Oncol"},{"issue":"32","key":"1188_CR33","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1200\/jco.2014.60.3787","volume":"33","author":"M Duvic","year":"2015","unstructured":"Duvic M, Tetzlaff MT, Gangar P et al (2015) Results of a\u00a0phase II trial of brentuximab vedotin for\n\t\t\t\t\t\tCD30 + cutaneous T\u2011cell lymphoma and lymphomatoid papulosis. J\u00a0Clin Oncol 33(32):3759\u20133765. doi:\n                        10.1200\/jco.2014.60.3787","journal-title":"J Clin Oncol"},{"issue":"12","key":"1188_CR34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","volume":"125","author":"M Duvic","year":"2015","unstructured":"Duvic M, Pinter-Brown LC, Foss FM et al (2015) Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T\u2011cell lymphoma. Blood 125(12):1883\u20131889. doi:\n                        10.1182\/blood-2014-09-600924","journal-title":"Blood"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-017-1188-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T13:04:21Z","timestamp":1511183061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-017-1188-8"}},"subtitle":["Minimal risk of acute toxicities","Minimales Risiko f\u00fcr akute Toxizit\u00e4ten"],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1007\/s00066-017-1188-8","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]}}}